Display options
Cite
Beran A, Mhanna M, Wahood W, et al. Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Am J Ther. 2021;29(1):e95-e98doi: 10.1097/MJT.0000000000001397.
Beran, A., Mhanna, M., Wahood, W., Ghazaleh, S., Sajdeya, O., Kalifa, M., Ayesh, H., Srour, O., Mhanna, A. S., Altorok, N., & Assaly, R. (2021). Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. American journal of therapeutics, 29(1), e95-e98. https://doi.org/10.1097/MJT.0000000000001397
Beran, Azizullah, et al. "Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis." American journal of therapeutics vol. 29,1 (2021): e95-e98. doi: https://doi.org/10.1097/MJT.0000000000001397
Beran A, Mhanna M, Wahood W, Ghazaleh S, Sajdeya O, Kalifa M, Ayesh H, Srour O, Mhanna AS, Altorok N, Assaly R. Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Am J Ther. 2021 Dec 23;29(1):e95-e98. doi: 10.1097/MJT.0000000000001397. PMID: 34117141.
Copy Download .nbib Format: NLM
Share it on

Am J Ther. 2021 Dec 23;29(1):e95-e98. doi: 10.1097/MJT.0000000000001397.

Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.

American journal of therapeutics

Azizullah Beran, Mohammed Mhanna, Waseem Wahood, Sami Ghazaleh, Omar Sajdeya, Muhamad Kalifa, Hazem Ayesh, Omar Srour, Asmaa S Mhanna, Nezam Altorok, Ragheb Assaly

Affiliations

  1. Department of Internal Medicine, University of Toledo, Toledo, OH.
  2. Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, FL.
  3. Department of Pediatrics, University of Toledo, OH.
  4. Division of Rheumatology, University of Toledo, Toledo, OH.
  5. Division of Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH.

PMID: 34117141 DOI: 10.1097/MJT.0000000000001397

[No abstract available.]

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–848. - PubMed
  2. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693–704. - PubMed
  3. Brunetti L, Diawara O, Tsai A, et al. Colchicine to weather the cytokine storm in hospitalized patients with COVID-19. J Clin Med. 2020;9:2961. - PubMed
  4. Slobodnick A, Shah B, Krasnokutsky S, et al. Update on colchicine, 2017. Rheumatology (Oxford). 2018;57:i4–i11. - PubMed
  5. Mansouri N, Marjani M, Tabarsi P, et al. Successful treatment of covid-19 associated cytokine release syndrome with colchicine. A case report and review of literature. Immunol Invest. 2020:1–7. - PubMed
  6. Higgins JPT TJ, Chandler J, Cumpston M, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2. Cochrane. 2021. - PubMed
  7. Balk EM, Earley A, Patel K, et al. Empirical Assessment of Within-Arm Correlation Imputation in Trials of Continuous Outcomes. Agency for Healthcare Research and Quality (US); 2012. - PubMed
  8. Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, et al. Colchicine as a possible therapeutic option in COVID-19 infection. Clin Rheumatol. 2020;39:2485–2486. - PubMed
  9. Chen LD, Zhang ZY, Wei XJ, et al. Association between cytokine profiles and lung injury in COVID-19 pneumonia. Respir Res. 2020;21:201. - PubMed
  10. Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care 2020;8:49. - PubMed
  11. Demidowich AP, Levine JA, Apps R, et al. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. Int J Obes (Lond). 2020;44:1793–1799. - PubMed
  12. Tardif JC, Bouabdallaoui N, L'Allier PL, et al. Efficacy of Colchicine in Non-hospitalized Patients With COVID-19. medRxiv; 2021:2021.01.26.21250494. - PubMed
  13. Hariyanto TI, Halim DA, Jodhinata C, et al. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Clin Exp Pharmacol Physiol. 2021;44:1793–1799. - PubMed
  14. Salah HM, Mehta JL. Meta-analysis of the effect of colchicine on mortality and mechanical ventilation in COVID-19. Am J Cardiol. 2021;145:170–172. - PubMed
  15. Vrachatis DA, Giannopoulos GV, Deftereos SG, et al. Impact of colchicine on mortality in patients with COVID-19: a meta-analysis. Hellenic J Cardiol. 2021. - PubMed
  16. Kelly J, Sadeghieh T, Adeli K, Peer review in scientific publications: benefits, critiques, & A survival guide. EJIFCC, 2014. 25:227–243. - PubMed

Publication Types